<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: CARRONADE CAPITAL MANAGEMENT, LP -->
          <cik>0001866872</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <dateOfEvent>11/13/2026</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001332349</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>112463104</issuerCusipNumber>
        </issuerCusips>
        <issuerName>Brookdale Senior Living Inc.</issuerName>
        <address>
          <com:street1>105 WESTWOOD PLACE</com:street1>
          <com:street2>SUITE 400</com:street2>
          <com:city>BRENTWOOD</com:city>
          <com:stateOrCountry>TN</com:stateOrCountry>
          <com:zipCode>37027</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Dan Gropper</personName>
          <personPhoneNum>(203) 485-0880</personPhoneNum>
          <personAddress>
            <com:street1>Carronade Capital Management, LP</com:street1>
            <com:street2>17 Old Kings Highway South, Suite 140</com:street2>
            <com:city>Darien</com:city>
            <com:stateOrCountry>CT</com:stateOrCountry>
            <com:zipCode>06820</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Ele Klein</personName>
          <personPhoneNum>(212) 756-2000</personPhoneNum>
          <personAddress>
            <com:street1>McDermott Will &amp; Schulte LLP</com:street1>
            <com:street2>919 Third Avenue</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001866872</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>CARRONADE CAPITAL MANAGEMENT, LP</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>13787822.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>13787822.00</sharedDispositivePower>
        <aggregateAmountOwned>13787822.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>5.8</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
        <commentContent>Includes 3,000,000 shares of Common Stock underlying call options.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Dan Gropper</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>13787822.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>13787822.00</sharedDispositivePower>
        <aggregateAmountOwned>13787822.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>5.8</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>Includes 3,000,000 shares of Common Stock underlying call options.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.01 per share</securityTitle>
        <issuerName>Brookdale Senior Living Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>105 WESTWOOD PLACE</com:street1>
          <com:street2>SUITE 400</com:street2>
          <com:city>BRENTWOOD</com:city>
          <com:stateOrCountry>TN</com:stateOrCountry>
          <com:zipCode>37027</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>This statement on Schedule 13D (this "Schedule 13D") is filed by:

(i) Carronade Capital Management, LP ("Carronade Capital Management"), a Delaware limited partnership, with respect to the shares of Common Stock, par value $0.01 (the "Common Stock"), of Brookdale Senior Living Inc. (the "Issuer") held by certain funds and accounts (the "Carronade Funds") for which it serves as the investment manager or trading advisor; and

(ii) Dan Gropper ("Mr. Gropper"), the Managing Member of Carronade Capital Management GP, LLC ("Carronade Capital GP"), a Delaware limited liabity company, the general partner of Carronade Capital Management, with respect to the shares of Common Stock held by the Carronade Funds.

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."</filingPersonName>
        <principalBusinessAddress>The address of the business office of each of the Reporting Persons and Carronade Capital GP is 17 Old Kings Highway South, Suite 140, Darien, Connecticut 06820.</principalBusinessAddress>
        <principalJob>The principal business of: (i) Carronade Capital Management is to provide investment management services, including serving as the investment manager of the Carronade Funds; (ii) Mr. Gropper is acting as Managing Member of Carronade Capital GP; and (iii) Carronade Capital GP is acting as general partner of Carronade Capital Management.</principalJob>
        <hasBeenConvicted>None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>None of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>Carronade Capital Management is a Delaware limited partnership. Mr. Gropper is a United States citizen. Carronade Capital GP is a Delaware limited liability company.</citizenship>
      </item2>
      <item3>
        <fundsSource>The shares of Common Stock held by the Carronade Funds were purchased with the working capital of the Carronade Funds. A total of approximately $90.5 million (excluding commissions) was paid to acquire the shares of Common Stock held by the Carronade Funds.

The shares of Common Stock held by the Carronade Funds may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Because other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock reported herein.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The Reporting Persons acquired the shares of Common Stock reported herein for investment purposes because they believe the shares are undervalued and represent an attractive investment opportunity.

In particular, the Reporting Persons believe there is a significant gap between the valuation implied by the current market price of the Common Stock and the intrinsic value of the Issuer's business and assets, relative to both public comparables and private market values. The Reporting Persons have had, and expect to continue, discussions with the Issuer's Board of Directors (the "Board") and management regarding strategic opportunities to maximize shareholder value, including the Issuer's ability to realize the full value of its business and assets.

The topics of these discussions have covered, and may in the future cover, a range of matters, including capital allocation, investor communications, management, board composition, portfolio optimization, mergers and acquisitions strategy, REIT conversion, a review of some or all of the Issuer's assets, and other opportunities to maximize shareholder value. The Reporting Persons may also have similar conversations with other stockholders or other interested parties, such as industry analysts, existing or potential strategic partners, competitors, investment professionals, and other investors, and may exchange information with any such persons or the Issuer pursuant to appropriate confidentiality or similar agreements.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and depending upon various factors, including, without limitation, the Issuer's financial position and strategic direction, the outcome of any discussions or matters referenced above, overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor (i) to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer, including through transactions involving the Common Stock and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer in the open market or in private transactions, including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) to enter into transactions that increase or hedge their economic exposure to the Common Stock without affecting their beneficial ownership of the Common Stock. In addition, the Reporting Persons may, at any time and from time to time, (i) review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto and (ii) consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and percentages of the Common Stock beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D are calculated based upon 239,316,054 shares of Common Stock outstanding as of November 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 6, 2026.</percentageOfClassSecurities>
        <numberOfShares>See rows (7) through (10) of the cover pages to this Schedule 13D for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.</numberOfShares>
        <transactionDesc>All information concerning transactions in the Common Stock effected by the Reporting Persons during the past sixty (60) days is set forth in Schedule A hereto and is incorporated by reference herein.</transactionDesc>
        <listOfShareholders>No person (other than the Reporting Persons and the Carronade Funds) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock reported herein.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>The Carronade Funds have entered into long call options (the "Call Options") relating to 3,000,000 shares of Common Stock with a strike price of $10.00 and an expiration date of April 16, 2027. The counterparties to the Call Options are unaffiliated third party financial institutions.

Except as set forth herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 hereof and between such persons and any person with respect to any securities of the Issuer, including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 99.1:  Joint Filing Agreement</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>CARRONADE CAPITAL MANAGEMENT, LP</signatureReportingPerson>
        <signatureDetails>
          <signature>By: /s/ Rinarisa Coronel DeFronze</signature>
          <title>Rinarisa Coronel DeFronze, Chief Compliance Officer &amp; Counsel</title>
          <date>11/19/2026</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Dan Gropper</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Dan Gropper</signature>
          <title>Dan Gropper, individually</title>
          <date>11/19/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
